Canada Markets open in 6 hrs 59 mins


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
2.9000+0.0500 (+1.75%)
At close: 04:00PM EST


Rue du Centre 172
Saint-Sulpice 1025
41 21 694 10 60

IndustryHealth Information Services
Full Time Employees518

Key Executives

NameTitlePayExercisedYear Born
Dr. Jurgi Camblong M.B.A., Ph.D.Co-Founder, CEO & DirectorN/AN/A1979
Mr. Ross Jordan Muken B.Sc.Sr. VP & CFON/AN/A1980
Mr. Abhimanyu VermaSr. VP & CTON/AN/AN/A
Dr. Zhenyu Xu Ph.D.Sr. VP & Chief Scientific OfficerN/AN/A1982
Jennifer PottageHead of Investor RelationsN/AN/AN/A
Mr. Daan van Well L.L.M., M.B.A.Sr. VP, Chief Legal Officer & Gen. CounselN/AN/A1974
Ms. Manuela Da Silva Valente B.A.Sr. VP & Chief People OfficerN/AN/A1970
Dr. Thierry ColinSr. VP of Radiomics Bus. AreaN/AN/AN/A
Dr. Philippe Menu M.B.A., M.D., Ph.D.Sr. VP & Chief Medical OfficerN/AN/A1981
Ms. Lara HashimotoSr. VP & Chief Bus. OfficerN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.

Corporate Governance

SOPHiA GENETICS SA’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.